Retrospective analysis reveals risk factors and management outcomes of neonatal polycythemia in neonates, indicating a need for guideline-based approaches.
Objective: To describe risk factors, clinical manifestations, management, and outcomes of neonatal polycythemia in a large Turkish single-center cohort and to integrate these findings with recent literature.Material and Methods: Retrospective analysis of 99 neonates admitted between May 2006 and December 2007.Results: Small for gestational age (SGA, 24.2%) and large for gestational age (LGA, 15.2%) were major risk factors. Symptoms occurred in 73.7%, most commonly plethora (48.5%), gastrointestinal signs (20.2%), and central nervous system involvement (12.1%). Partial exchange transfusion (PET) was performed in 36.3%. Follow-up showed mild developmental delays (9–25%), without a significant difference between management groups.Conclusion: Neonatal polycythemia remains clinically important with consistent risk factors and manifestations. This cohort supports guideline-based conservative-first management, selective PET, and structured follow-up.
No takes yet. Share an insight, caveat, or question.
Yücel et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: